Search research articles
Contact Us
Filters
Showing results (241-250 of 243) with videos related to
Page
of 25
Sort By:
You have reached the last page of results.
This site can display upto 243 results.
Antimicrobial Agents and Chemotherapy
|
May 1, 1996
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program
A Cometta, T Calandra, H Gaya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 29, 2003
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy
A Cometta, W V Kern, R De Bock, et al.
Nature Medicine
|
July 14, 1998
Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy
S Fleury, R J de Boer, G P Rizzardi, et al.
Page
of 25
Search research articles
Search
Showing results (241-250 of 243) with videos related to
Sort By:
Page
of 25
You have reached the last page of results.
This site can display upto 243 results.
Antimicrobial Agents and Chemotherapy
|
May 1, 1996
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program
A Cometta, T Calandra, H Gaya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 29, 2003
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy
A Cometta, W V Kern, R De Bock, et al.
Nature Medicine
|
July 14, 1998
Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy
S Fleury, R J de Boer, G P Rizzardi, et al.
Page
of 25